hesperidin has been researched along with Depression in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bernroider, M; Chen, L; Feng, GW; Genser, J; Hierlmeier, G; Hu, XX; Lan, YJ; Leitner, C; Li, H; Lin, DF; Lyu, KY; Meng, L; Neubauer, F; Qu, X; Shen, T; Sun, RC; Wang, C; Weng, SF; Wolf, R; Xu, QY; Yang, SX; Yao, ZM; Zhang, LZ; Zhang, M; Zhang, NX; Zhang, X; Zhu, DX; Zhu, JJ; Zhu, S | 1 |
| Cao, H; Huang, W; Lin, R; Liu, L; Nie, K; Peng, L; Yang, D; Zeng, Y; Zhang, M; Zhou, X | 1 |
| Feng, F; Zhang, Q | 1 |
| Antunes, MS; Araújo, SM; Boeira, SP; Bortolotto, VC; Cattelan Souza, L; Ladd, AABL; Ladd, FVL; Moreira, AL; Nogueira, CW; Prigol, M; Silva, MRP | 1 |
| Alizadeh Makvandi, A; Amiri Moghaddam, S; Khalili, M; Roghani, M | 1 |
| Chen, YJ; Liu, YW; Zhang, MY; Zhang, YM; Zhu, X | 1 |
| Abbasi, MM; Ghorbanihaghjo, A; Kosari-Nasab, M; Salari, AA; Shokouhi, G | 1 |
| Fu, H; Gao, X; Li, Y; Liu, L; Tong, Y; Wang, H; Wen, K; Xiao, D; Yong, J; Zhang, X; Zhao, J | 1 |
| Bai, Y; Dai, G; Jing, W; Ju, W; Song, L; Song, S; Sun, H; Xu, M; Zhang, W; Zhang, Y | 1 |
| Cai, L; Li, R; Wu, QQ; Wu, TN | 1 |
| Du, B; Leng, X; Liu, F; Ren, F; Tang, X; Zhang, C; Zhao, G | 1 |
| Abdallah, HM; El-Khatib, AS; El-Marasy, SA; El-Shabrawy, OA; El-Shenawy, SM; Kenawy, SA | 1 |
| Li, M; Qin, B; Shao, H; Zhang, X | 1 |
| Altvater, EET; Antunes, MS; Boeira, SP; de Oliveira Espinosa, D; Donato, F; Giacomeli, R; Gomes, NS; Jesse, CR; Ruff, JR | 1 |
| Boeira, SP; de Gomes, MG; Del Fabbro, L; Filho, CB; Goes, AT; Jesse, CR; Souza, LC | 1 |
15 other study(ies) available for hesperidin and Depression
| Article | Year |
|---|---|
Topics: Accidents, Occupational; Adult; Animals; Anxiety; beta Catenin; Chromatography, High Pressure Liquid; Chronic Disease; Cities; Depression; Drugs, Chinese Herbal; Flavonoids; Heat Stroke; Hesperidin; Humans; Hyperplasia; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-10; Interleukin-6; Kruppel-Like Factor 4; Macrophages, Alveolar; Medical Staff; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Occupational Health; Occupational Injuries; Occupational Stress; Occupations; PPAR gamma; Pulmonary Fibrosis; RNA, Messenger; Sanitation; Silicon Dioxide; Sinusitis; Stress, Psychological; Surveys and Questionnaires; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; X-Box Binding Protein 1; Young Adult | 2022 |
Hesperidin may improve depressive symptoms by binding NLRP3 and influencing the pyroptosis pathway in a rat model.
Topics: Animals; Caspase 1; Depression; Depressive Disorder, Major; Hesperidin; Humans; Inflammasomes; Molecular Docking Simulation; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats | 2023 |
The Effects of Different Varieties of
Topics: Animals; Chromatography, High Pressure Liquid; Depression; Disaccharides; Disease Models, Animal; Drug Synergism; Drugs, Chinese Herbal; Flavanones; Hesperidin; Intestinal Absorption; Iridoids; Male; Rats; Rats, Sprague-Dawley | 2019 |
Hesperidin Ameliorates Anxiety-Depressive-Like Behavior in 6-OHDA Model of Parkinson's Disease by Regulating Striatal Cytokine and Neurotrophic Factors Levels and Dopaminergic Innervation Loss in the Striatum of Mice.
Topics: Animals; Anxiety; Behavior, Animal; Corpus Striatum; Cytokines; Depression; Dopaminergic Neurons; Hesperidin; Male; Mice; Nerve Growth Factors; Neuroprotective Agents; Oxidopamine; Parkinson Disease, Secondary | 2020 |
Hesperetin ameliorates electroconvulsive therapy-induced memory impairment through regulation of hippocampal BDNF and oxidative stress in a rat model of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Electroconvulsive Therapy; Hesperidin; Hippocampus; Male; Maze Learning; Memory Disorders; Oxidative Stress; Rats; Rats, Wistar; Reserpine | 2021 |
Hesperetin ameliorates diabetes-associated anxiety and depression-like behaviors in rats via activating Nrf2/ARE pathway.
Topics: Animals; Anxiety; Depression; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Hesperidin; NF-E2-Related Factor 2; Oxidative Stress; Rats | 2021 |
Hesperidin attenuates depression-related symptoms in mice with mild traumatic brain injury.
Topics: Animals; Antidepressive Agents; Brain Concussion; Cytokines; Depression; Depressive Disorder; Disease Models, Animal; Flavonoids; Hesperidin; Hippocampus; Inflammation; Interleukin-1beta; Male; Malondialdehyde; Mice; Nerve Growth Factors; Neuroprotective Agents; Oxidative Stress; Tumor Necrosis Factor-alpha | 2018 |
The antidepressant effects of hesperidin on chronic unpredictable mild stress-induced mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cell Survival; Cytokines; Depression; Hesperidin; HMGB1 Protein; Male; Membrane Glycoproteins; Mice; NF-kappa B; PC12 Cells; Protein-Tyrosine Kinases; Rats; Receptor for Advanced Glycation End Products; Signal Transduction; Stress, Psychological | 2019 |
Comparative pharmacokinetic study of four major bioactive components after oral administration of Zhi-Zi-Hou-Po decoction in normal and corticosterone-induced depressive rats.
Topics: Administration, Oral; Animals; Biphenyl Compounds; Corticosterone; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Hesperidin; Iridoids; Lignans; Limit of Detection; Linear Models; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results | 2019 |
[Effect of hesperidin on behavior and HPA axis of rat model of chronic stress-induced depression].
Topics: Administration, Oral; Animals; Behavior, Animal; Corticosterone; Corticotropin-Releasing Hormone; Depression; Fluoxetine; Gene Expression Regulation; Hesperidin; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Models, Animal; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Stress, Psychological; Sucrose; Swimming; Up-Regulation | 2013 |
Antidepressant-like effects of the hydroalcoholic extracts of Hemerocallis citrina and its potential active components.
Topics: Animals; Antidepressive Agents; Depression; Dopamine; Hemerocallis; Hesperidin; Hindlimb Suspension; Male; Mice, Inbred ICR; Phytotherapy; Plant Extracts; Rutin; Serotonin | 2014 |
Anti-depressant effect of hesperidin in diabetic rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Brain-Derived Neurotrophic Factor; Depression; Diabetes Mellitus, Experimental; Fluoxetine; Glutathione; Hesperidin; Hyperglycemia; Inflammation; Interleukin-6; Male; Malondialdehyde; Oxidative Stress; Rats, Wistar; Streptozocin | 2014 |
Hesperidin Alleviates Lipopolysaccharide-Induced Neuroinflammation in Mice by Promoting the miRNA-132 Pathway.
Topics: Animals; Antidepressive Agents; Brain Chemistry; Cytokines; Depression; Dose-Response Relationship, Drug; Hesperidin; Inflammation; Lipopolysaccharides; Metabolic Networks and Pathways; Mice; MicroRNAs | 2016 |
Hesperidin reverses cognitive and depressive disturbances induced by olfactory bulbectomy in mice by modulating hippocampal neurotrophins and cytokine levels and acetylcholinesterase activity.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Cytokines; Depression; Hesperidin; Hippocampus; Male; Maze Learning; Mice; Olfactory Bulb | 2016 |
Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Exploratory Behavior; Fluoxetine; Hesperidin; Hindlimb Suspension; Immobility Response, Tonic; Male; Mice; Motor Activity; Prazosin; Receptor, Serotonin, 5-HT1A | 2013 |